Catalyst Wire Dossier Catalyst Wire Dossier

Tat protein-based HIV vaccine

recombinant Tat protein vaccine · Istituto Superiore di Sanità
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tat protein-based HIV vaccine, covering 2011-03-01 to 2011-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein [Phase 1]

See pricing